cta-logo01
  • News

    Most Read

    • AstraZeneca’s antibody reduces exacerbation rates in asthma trial
    • Medable to integrate Seqster technology in decentralised trial platform
    • Innovent doses first patient in US trial of advanced malignancy treatment

    Most Recent

    Clinical Trials

    AstraZeneca’s antibody reduces exacerbation rates in asthma trial

    01 Mar 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • OCT West Coast: how can decentralisation help optimise rare disease trials?
    • OCT West Coast: IQVIA’s Nagaraja Srivatsan talks decentralised trials and the future of clinical research
    • Neurology trends: Stroke leads Twitter mentions in Q4 2020

    Most Recent

    Clinical Trials

    OCT West Coast: how can decentralisation help optimise rare disease trials?

    26 Feb 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • AstraZeneca’s antibody reduces exacerbation rates in asthma trial
    • Cardiovascular trends: Imaging leads Twitter mentions in Q4 2020
    • Gastrointestinal trials and hematological disorders have highest proportion of studies disrupted by Covid-19

    Most Recent

    Clinical Trials

    AstraZeneca’s antibody reduces exacerbation rates in asthma trial

    01 Mar 2021
  • Themes
  • Deals

    Most Read

    • Altasciences completes acquisition of US-based CRO WCCT Global
    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink

    Most Recent

    Clinical Trials

    Altasciences completes acquisition of US-based CRO WCCT Global

    19 Feb 2021
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Kolabtree
    • VaLea Clinical Trials
    • Linari NanoTech

    Most Recent

    Clinical Trials

    Kolabtree

    24 Feb 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
OCT West Coast: how can decentralisation help optimise rare disease trials?

OCT West Coast: how can decentralisation help optimise rare disease trials?

Throughout the Covid-19 pandemic, decentralised clinical trials (DCTs) have been imperative for the continuation of...

26th February 2021
Real-world setting study shows Velphoro effective in CKD-HP management

Real-world setting study shows Velphoro effective in CKD-HP management

On 1 February, the Clinical Kidney Journal published results from a real-world setting study, the...

15th February 2021
Spotlight on mRNA vaccines: Covid-19 approvals highlight a novel competitive landscape in oncology

Spotlight on mRNA vaccines: Covid-19 approvals highlight a novel competitive landscape in oncology

The ongoing Covid-19 pandemic has yielded an unexpected advancement in the pharmaceutical industry with the...

9th February 2021
Brexit deal secures UK access to EU’s €95.5B research and innovation programme, Horizon Europe

Brexit deal secures UK access to EU’s €95.5B research and innovation programme, Horizon Europe

8th February 2021
Two trials show complexity of managing thromboembolism in Covid-19 patients

Two trials show complexity of managing thromboembolism in Covid-19 patients

24th December 2020
How Covid-19 has accelerated ‘digital health’ and the evolution of clinical trials

How Covid-19 has accelerated ‘digital health’ and the evolution of clinical trials

The monumental challenges brought about by the Covid-19 pandemic have forced the healthcare and life...

22nd December 2020
The benefit of running clinical trials in Asia-Pacific for biotech companies

The benefit of running clinical trials in Asia-Pacific for biotech companies

21st December 2020
Roche’s Ocrevus set to top $7.6bn in sales by 2028 backed by new dosing approval

Roche’s Ocrevus set to top $7.6bn in sales by 2028 backed by new dosing approval

On 14 December, the US Food and Drug Administration (FDA) approved a shorter two-hour infusion...

18th December 2020
Hope for chronic kidney disease as KBP Biosciences’ KBP-5074 shows promise

Hope for chronic kidney disease as KBP Biosciences’ KBP-5074 shows promise

In early December, KBP Biosciences shared results for their BLOCK-CKD Phase IIb study, which has...

18th December 2020
Healthcare 5.0 reimagined

Healthcare 5.0 reimagined

17th December 2020

Latest News

Clinical Trials

AstraZeneca’s antibody reduces exacerbation rates in asthma trial

01 Mar 2021
Technology

Medable to integrate Seqster technology in decentralised trial platform

01 Mar 2021
Clinical Trials

Innovent doses first patient in US trial of advanced malignancy treatment

01 Mar 2021
Clinical Trials

Partner Therapeutics’ inhaled sargramostim improves lung function in trial

01 Mar 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
CTArena_white-logo_

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more